CDC shortens coronavirus quarantine period, adds travel-related testing recommendations


Quarantine can end after 10 days without COVID-19 test, or seven days with negative result, officials say

The Centers for Disease Control and Prevention (CDC) on Wednesday announced shorter coronavirus-related quarantine periods ahead of anticipated holiday travel.

The CDC announced two acceptable quarantine periods, though noted that the previously-established 14 days of quarantine is the best way to reduce risk of virus spread. Officials said quarantine can now end after 10 days without a COVID-19 test, if the person reports no symptoms, or after seven days with a negative test result if the person reports no symptoms.

The agency advised people should still watch for symptoms for COVID-19 14 days after exposure. The announcement arises from analysis of new research and modeling data. The shorter length of quarantine is hoped to reduce economic hardship and lessen the stress on the public health system amid a rising number of infections.

CDC Director Dr. Robert Redfield elaborated on the new changes in a separate conversation on Wednesday with the U.S. Chamber of Commerce Foundation.

“And that guidance is, again, based on data that we gathered and modeling of that data that if you isolate for 10 days that the probability that you will start replicating the virus after that is about one percent,” Redfield said.

Dr. Henry Walke, incident manager for CDC’s COVID-19 response, advised Americans to postpone travel with the upcoming winter holiday.

“If you do decide to travel, the CDC recommends that travelers consider getting tested one to three days before travel, and again three to five days after travel,” Walke said on a call. “This should be done in combination with reducing non-essential activities for seven days after travel.”

Read full article here.

Kayla Rivas – Fox News – December 2, 2020.

Want More Investigative Content?

Curate RegWatch
Curate RegWatch
In addition to our original coverage, RegWatch curates top stories on issues and impacts arising from the regulation of economic, social and environmental activity in Canada and the U.S.


Please enter your comment!
Please enter your name here


Out of Sync | Sweanor Calls For “Rethink” On Vaping at...

What’s driving Health Canada’s war on vaping? Does the regulator favour drug harm reduction over tobacco harm reduction? And is it too late to...